Taiwan FDA registration 8aadd6b7349c6555cbfdb18e92baea85
Constant insulin C-/ immunoassay group
TW: 常盈胰島素C-/類免疫試劑組
Taiwan·Risk Class 1·DIAGNOSTIC SYSTEMS LABORATORIES, INC.·Registered May 16, 2006 – May 16, 2011CancelledRegistration details
- Analysis ID
- 8aadd6b7349c6555cbfdb18e92baea85
- Customs Code
- DHA04400450007
Company information
- Manufacturer
- DIAGNOSTIC SYSTEMS LABORATORIES, INC.
- Manufacturer Country
- United States
- Authorized Representative
- WOLCH ENTERPRISES INC.
Product details
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1135 胰島素前質C-肽類試驗系統
- Import Information
- import
Dates and status
- Registration Date
- May 16, 2006
- Expiry Date
- May 16, 2011
- Cancellation Date
- Nov 26, 2012
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Constant insulin C-/ immunoassay group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 8aadd6b7349c6555cbfdb18e92baea85 and manufactured by DIAGNOSTIC SYSTEMS LABORATORIES, INC.. The authorized representative in Taiwan is WOLCH ENTERPRISES INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices